文献速递心境障碍

氯胺酮在抑郁症患者与健康受试者中具有不同的电生理和行为效应

Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects.
PubMed 文献 · Mol Psychiatry · 2018-02-27

该双盲、安慰剂对照、随机交叉试验纳入35例未用药重性抑郁障碍(MDD)患者和25名健康对照,使用脑磁图γ功率作为稳态平衡的替代指标评估0.5 mg/kg氯胺酮的作用。MDD患者抑郁症状显著改善,健康对照在给药后1天内抑郁症状出现 modest 但显著的增加。两组静息γ功率均升高;在MDD患者中,基线γ功率调节给药后γ功率与抗抑郁反应的关系,提示基于稳态失调方向的生物学亚型。

要点

  • 氯胺酮使MDD患者和健康对照的静息γ功率均升高。
  • MDD患者抑郁症状显著改善,健康对照抑郁症状短暂轻度增加。
  • 基线γ功率调节MDD患者给药后γ功率与抗抑郁疗效的关系。

核心结论

  • 氯胺酮在MDD患者与健康对照中产生不同的行为效应,且基线γ功率可调节MDD患者给药后γ功率与抗抑郁反应的关系,提示基于稳态失调方向的生物学亚型。

研究设计与样本

  • 双盲、安慰剂对照、随机交叉试验,纳入35例未用药MDD患者和25名健康对照,使用脑磁图γ功率作为稳态平衡替代指标,氯胺酮剂量为0.5 mg/kg。

主要发现

  • MDD患者抑郁症状显著改善,健康对照在氯胺酮给药后1天内抑郁症状出现 modest 但显著的增加。
  • 两组静息γ功率在氯胺酮后均升高。
  • 在MDD患者中,γ功率与抗抑郁效应 magnitude 不相关;基线γ功率调节给药后γ功率与抗抑郁反应的关系:基线γ较低者给药后γ越高反应越好,基线γ较高者呈倒置关系。
  • 该关系在多个涉及MDD病理生理网络的脑区中观察到。

临床怎么用

  • 基线γ功率可能作为氯胺酮抗抑郁反应的调节因素,提示未来可基于稳态失调方向对MDD患者进行亚型划分。
  • 仅从健康对照研究推断氯胺酮作用机制可能不充分,需结合MDD患者数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ketamine's mechanism of action was assessed using gamma power from magnetoencephalography (MEG) as a proxy measure for homeostatic balance in 35 unmedicated subjects with major depressive disorder (MDD) and 25 healthy controls enrolled in a double-blind, placebo-controlled, randomized cross-over trial of 0.5 mg/kg ketamine. MDD subjects showed significant improvements in depressive symptoms, and healthy control subjects exhibited modest but significant increases in depressive symptoms for up to 1 day after ketamine administration. Both groups showed increased resting gamma power following ketamine. In MDD subjects, gamma power was not associated with the magnitude of the antidepressant effect. However, baseline gamma power was found to moderate the relationship between post-ketamine gamma power and antidepressant response; specifically, higher post-ketamine gamma power was associated with better response in MDD subjects with lower baseline gamma, with an inverted relationship in MDD subjects with higher baseline gamma. This relationship was observed in multiple regions involved in networks hypothesized to be involved in the pathophysiology of MDD. This finding suggests biological subtypes based on the direction of homeostatic dysregulation and has important implications for inferring ketamine's mechanism of action from studies of healthy controls alone.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Nugent AC, Ballard ED, Gould TD, et al. Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects. Mol Psychiatry. 2018. PMID: 29487402. doi:10.1038/s41380-018-0028-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。